Breast cancer survivor and researcher LaShae Rolle studies how individualized strength training during chemo boosts physical, ...

Dr. Jim Omel, who was diagnosed with multiple myeloma in 1997, explained how the treatment landscape has changed over nearly ...

More than half of patients with low platelets treated with Vonjo had a platelet response, with median platelets rising 58% and hemoglobin increasing.

Living with stage 4 cancer taught me the power of community; connecting with others provides guidance, support, and hope in ...

Real-world data show that Enhertu benefits those with HR+ breast cancer, whereas Trodelvy is effective as an initial treatment for HER2-null/HER2– disease.

Dr. Jacob Sands explained that he believes patients should be having more personalized, nuanced conversations with their ...

There are many reliable resources available to patients with kidney cancer, as well as their families and caregivers.

Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.

Follicular lymphoma survivor Troy Anderson credited acupuncture and nutrition guidance with easing treatment side effects and ...

Among patients with advanced gastrointestinal stromal tumors, Gleevec and Mektovi was associated with benefits in progression and survival.

When I was diagnosed with peritoneal mesothelioma at 21 years old, the doctors gave me 18 months to live; that was 18 years ...

About one in six men with grade group 1 prostate cancer have higher-risk disease, showing outcomes vary and biopsy grade may ...